Report Overview:
Inhalation capsules are a new and successful technique for directly delivering drugs to the respiratory system, providing a focused approach to treating a variety of respiratory disorders. These capsules, also known as dry powder inhalers (DPIs), have gained popularity in the field of respiratory medicine due to their ease of use, portability, and ability to provide immediate relief for people suffering from asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
This report provides a deep insight into the global Dry Powder Inhalation Capsules market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Market Value:
The global Dry Powder Inhalation Capsules market size was estimated at USD 835 million in 2024 and is projected to reach USD 1459.36 million by 2032, exhibiting a CAGR of 6.40% during the forecast period.
By Types:
• Gelatin Capsules
• Hypromellose Capsules
By Applications: Asthma Treatment
COPD Management
Key players include:
• Capsugel (Lonza)
• ACG
• Qualicaps
• HealthCaps India
• Cipla
• Including or Excluding key companies relevant to your analysis.
